Grantham Mayo Van Otterloo & Co. LLC Has $13.14 Million Stock Position in CEMEX, S.A.B. de C.V. (NYSE:CX)

Grantham Mayo Van Otterloo & Co. LLC grew its position in CEMEX, S.A.B. de C.V. (NYSE:CX) by 62.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,330,556 shares of the construction company’s stock after acquiring an additional 900,200 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC’s holdings in CEMEX were worth $13,144,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. IFP Advisors Inc increased its holdings in CEMEX by 159.1% in the fourth quarter. IFP Advisors Inc now owns 4,986 shares of the construction company’s stock worth $28,000 after buying an additional 3,062 shares during the last quarter. Barclays PLC lifted its stake in CEMEX by 41.8% in the third quarter. Barclays PLC now owns 6,249 shares of the construction company’s stock valued at $38,000 after acquiring an additional 1,843 shares during the last quarter. Franklin Resources Inc. bought a new stake in CEMEX in the fourth quarter worth approximately $63,000. Envestnet Portfolio Solutions Inc. increased its stake in shares of CEMEX by 26.4% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 13,011 shares of the construction company’s stock worth $73,000 after purchasing an additional 2,720 shares during the last quarter. Finally, Banco Santander S.A. bought a new position in shares of CEMEX during the 4th quarter valued at $78,000. 82.97% of the stock is owned by hedge funds and other institutional investors.

CEMEX Price Performance

Shares of NYSE:CX opened at $5.15 on Monday. The company has a market cap of $7.47 billion, a price-to-earnings ratio of 8.18 and a beta of 1.28. The business has a 50 day moving average price of $6.16 and a 200 day moving average price of $5.87. The company has a quick ratio of 0.58, a current ratio of 0.82 and a debt-to-equity ratio of 0.43. CEMEX, S.A.B. de C.V. has a twelve month low of $4.93 and a twelve month high of $9.00.

CEMEX (NYSE:CX) last announced its quarterly earnings data on Thursday, February 13th. The construction company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.06. CEMEX had a net margin of 5.70% and a return on equity of 7.78%. Research analysts predict that CEMEX, S.A.B. de C.V. will post 0.69 earnings per share for the current year.

CEMEX Announces Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $0.0207 per share. The ex-dividend date was Monday, March 10th. CEMEX’s payout ratio is 12.70%.

Analysts Set New Price Targets

CX has been the subject of a number of recent research reports. The Goldman Sachs Group upped their price objective on shares of CEMEX from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Thursday, February 27th. Royal Bank of Canada increased their price objective on CEMEX from $5.00 to $6.00 and gave the company an “underperform” rating in a report on Monday, February 10th. Finally, Morgan Stanley lowered CEMEX from an “overweight” rating to an “equal weight” rating in a report on Wednesday, March 26th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CEMEX has a consensus rating of “Hold” and an average target price of $7.82.

About CEMEX

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.